BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 11395362)

  • 1. Pten, a protean tumor suppressor.
    Mutter GL
    Am J Pathol; 2001 Jun; 158(6):1895-8. PubMed ID: 11395362
    [No Abstract]   [Full Text] [Related]  

  • 2. [PTEN expression in endometrial cancer and the prognosis].
    Kanamori Y; Uegaki K; Kigawa J; Terakawa N
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():406-9. PubMed ID: 15535277
    [No Abstract]   [Full Text] [Related]  

  • 3. A surprising function for the PTEN tumor suppressor.
    Hopkin K
    Science; 1998 Nov; 282(5391):1027,1029-30. PubMed ID: 9841444
    [No Abstract]   [Full Text] [Related]  

  • 4. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
    Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
    Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling.
    Vazquez F; Sellers WR
    Biochim Biophys Acta; 2000 Feb; 1470(1):M21-35. PubMed ID: 10656987
    [No Abstract]   [Full Text] [Related]  

  • 6. PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.
    Paez J; Sellers WR
    Cancer Treat Res; 2003; 115():145-67. PubMed ID: 12613196
    [No Abstract]   [Full Text] [Related]  

  • 7. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis.
    Kim MJ; Cardiff RD; Desai N; Banach-Petrosky WA; Parsons R; Shen MM; Abate-Shen C
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2884-9. PubMed ID: 11854455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.
    Cantley LC; Neel BG
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4240-5. PubMed ID: 10200246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN: life as a tumor suppressor.
    Simpson L; Parsons R
    Exp Cell Res; 2001 Mar; 264(1):29-41. PubMed ID: 11237521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.
    Davies MA; Lu Y; Sano T; Fang X; Tang P; LaPushin R; Koul D; Bookstein R; Stokoe D; Yung WK; Mills GB; Steck PA
    Cancer Res; 1998 Dec; 58(23):5285-90. PubMed ID: 9850049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic effects of statins: acutely good, but chronically bad?
    Schulz R
    J Am Coll Cardiol; 2005 Apr; 45(8):1292-4. PubMed ID: 15837264
    [No Abstract]   [Full Text] [Related]  

  • 13. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
    Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
    Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel loss-of-function mutation (N48K) in the PTEN gene in a Spanish patient with Cowden disease.
    Vega A; Torres J; Torres M; Cameselle-Teijeiro J; Macia M; Carracedo A; Pulido R
    J Invest Dermatol; 2003 Dec; 121(6):1356-9. PubMed ID: 14675182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo.
    Ge NL; Rudikoff S
    Oncogene; 2000 Aug; 19(36):4091-5. PubMed ID: 10962569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoinositide signaling in urological disease.
    Theodorescu D
    J Urol; 2003 Jun; 169(6):2394-6. PubMed ID: 12771804
    [No Abstract]   [Full Text] [Related]  

  • 17. Stem cells. PTEN--coupling tumor suppression to stem cells?
    Penninger JM; Woodgett J
    Science; 2001 Dec; 294(5549):2116-8. PubMed ID: 11739945
    [No Abstract]   [Full Text] [Related]  

  • 18. MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells.
    Tanaka M; Koul D; Davies MA; Liebert M; Steck PA; Grossman HB
    Oncogene; 2000 Nov; 19(47):5406-12. PubMed ID: 11103942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological role of phosphatase PTEN in cancer and tissue injury healing.
    Tsugawa K; Jones MK; Sugimachi K; Sarfeh IJ; Tarnawski AS
    Front Biosci; 2002 May; 7():e245-51. PubMed ID: 11991859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation.
    Liu JL; Sheng X; Hortobagyi ZK; Mao Z; Gallick GE; Yung WK
    Mol Cell Biol; 2005 Jul; 25(14):6211-24. PubMed ID: 15988030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.